Biogened S.A. (WSE:BGD)

Poland flag Poland · Delayed Price · Currency is PLN
19.40
-0.20 (-1.02%)
At close: Apr 27, 2026
-28.68%
Market Cap 47.90M
Revenue (ttm) 114.04M
Net Income (ttm) 4.62M
Shares Out 2.46M
EPS (ttm) 1.88
PE Ratio 10.36
Forward PE n/a
Dividend 0.50 (2.58%)
Ex-Dividend Date Sep 11, 2025
Volume 75
Average Volume 449
Open 19.40
Previous Close 19.60
Day's Range 19.40 - 19.40
52-Week Range 17.30 - 32.00
Beta 0.20
RSI 49.09
Earnings Date May 15, 2026

About Biogened

Biogened S.A. produces and sells cosmetics and toiletries in Poland. The company offers dermo-cosmetics under the Dermedic brand; and thermal water. It also exports its products. The company was incorporated in 2007 and is headquartered in Lódz, Poland. [Read more]

Industry Pharmaceutical Preparations
Founded 2007
Employees 184
Stock Exchange Warsaw Stock Exchange
Ticker Symbol BGD
Full Company Profile

Financial Performance

In 2025, Biogened's revenue was 114.04 million, an increase of 2.81% compared to the previous year's 110.93 million. Earnings were 4.62 million, a decrease of -20.59%.

Financial Statements

News

There is no news available yet.